Suchergebnisse - "Vertosick, Emily"

PubPharm (28)

1

Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?

enthalten in: The Journal of urology | 2024

von Flores, J. | Vertosick, E. | Jenkins, L. | +9

CommentIn: J Urol. 2024 Mar;211(3):406. - PMID 38194478

2

Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging : Efficient Threshold or Legacy of the Past?

enthalten in: European urology focus | 2023

von Pellegrino, F. | Tin, A. | Martini, A. | +8

3

Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort

enthalten in: European urology | 2022

von Clements, M. | Vertosick, E. | Guerrios-Rivera, L. | +11

CommentIn: Eur Urol. 2022 Aug;82(2):170-171. - PMID 35105480

4

Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance

enthalten in: The Journal of urology | 2022

von Jibara, G. | Perera, M. | Vertosick, E. | +9

CommentIn: J Urol. 2022 Aug;208(2):244-245. - PMID 35536678

5

Clinical utility of subclassifying positive surgical margins at radical prostatectomy

enthalten in: BJU international | 2022

von Dason, S. | Vertosick, E. | Udo, K. | +11

6

Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume

enthalten in: Urology | 2021

von Vertosick, E. | Zappala, S. | Punnen, S. | +8

7

Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer : results from a surgical series at a high-volume institution

enthalten in: Minerva urology and nephrology | 2021

von Bravi, C. | Rosiello, G. | Fallara, G. | +13

8

Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels

enthalten in: The Prostate | 2020

von Li, W. | Bicak, M. | Sjoberg, D. | +6

9

Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years

enthalten in: The Journal of urology | 2020

von Vertosick, E. | Häggström, C. | Sjoberg, D. | +5

CommentIn: J Urol. 2020 Aug;204(2):287. - PMID 32432506

10

Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools

enthalten in: BMC medical research methodology | 2019

von Tolksdorf, J. | Kattan, M. | Boorjian, S. | +11